The lipid A component of meningococcal lipopolysaccharide was structurally characterized by using chemical modification methods, methylation analysis, 31P nuclear magnetic resonance, and laser desorption mass spectroscopy. It was shown that Neisseria meningitidis lipid A consists of a 1,4'-bisphosphorylated 1(1'-+6)-linked D-glucosamine disaccharide (lipid A backbone), both phosphate groups being largely replaced by O-phosphorylethanolamine. This disaccharide harbors two nonsubstituted hydroxyl groups at positions 4 and 6', the latter representing the attachment site of the oligosaccharide portion in lipopolysaccharide. In addition, it is substituted by up to six fatty acid residues. In the major lipid A component, representing a hexaacyl species, the hydroxyl groups at positions 3 and 3' carry (R)-3-hydroxydodecanoic acid [12:0(3-OH)], whereas the amino groups at positions 2 and 2' are substituted by (R)-3-(dodecanoyloxy)tetradecanoic acid Meningococcal infections represent a serious problem for small children and young adults in many parts of the world, the lethality being high even in developed countries (1, 5, 6). The causative agent, Neisseria meningitidis, like other gramnegative bacteria, possesses an endotoxin complex located in the bacterial outer cell membrane. Endotoxin (lipopolysaccharide [LPS]) is known to cause or to contribute to the severe symptoms of meningitis, culminating in irreversible shock (37). Meningococci vary in the ability to release endotoxin-containing outer membrane vesicles into the surroundings, both in vitro and in vivo (7). Recent studies performed with N. meningitidis isolates from the nasopharynx of carriers and from cerebrospinal fluid and blood samples from patients with meningococcal infection demonstrated that overproduction and liberation of endotoxin are strongly associated with pathogenicity, regardless of the serological group or serotype of the strain (8, 9).
Meningococcal infections represent a serious problem for small children and young adults in many parts of the world, the lethality being high even in developed countries (1, 5, 6) . The causative agent, Neisseria meningitidis, like other gramnegative bacteria, possesses an endotoxin complex located in the bacterial outer cell membrane. Endotoxin (lipopolysaccharide [LPS] ) is known to cause or to contribute to the severe symptoms of meningitis, culminating in irreversible shock (37) . Meningococci vary in the ability to release endotoxin-containing outer membrane vesicles into the surroundings, both in vitro and in vivo (7) . Recent studies performed with N. meningitidis isolates from the nasopharynx of carriers and from cerebrospinal fluid and blood samples from patients with meningococcal infection demonstrated that overproduction and liberation of endotoxin are strongly associated with pathogenicity, regardless of the serological group or serotype of the strain (8, 9) .
Lipid A represents the principal structural component responsible for the harmful biological activities of LPS (32) . To understand the structural parameters required for the expression of endotoxic activity, it appears important to know the precise chemical structure of the lipid A component of pathogenic gram-negative bacteria such as N. meningitidis. The present paper elucidates the primary structure of the lipid A component of N. meningitidis isolated from a strain (M986-NCV1) expressing the serogroup B LPS. It will be shown that this lipid A shares certain structural features with the well-studied enterobacterial lipid A but that it differs significantly in the substitution of the hydrophobic backbone and in the nature and locations of acyl chains. * Corresponding author.
MATERIALS AND METHODS
Microorganism and LPS. N. meningitidis M986-NCV1, a nonencapsulated variant of the group B strain M986, was obtained from the culture collection of the Center for Biologics Evaluation and Research. This strain was grown overnight in tryptic soy broth (Difco Laboratories, Detroit, Mich.) in 2.8 liters of baffled Fernbach flasks (Bellco Biological Glassware, Vineland, N.J.) at 37°C in a gyratory shaker at 140 rpm. The cells were collected by centrifugation at 10,000 x g for 15 min. LPS was isolated from acetone-dried cells by extraction with the phenol-water procedure (42) , followed by ultracentrifugation at 105,000 x g for 4 h and freeze-drying. The yield of the white, cottonlike material was about 3% (wt/wt) relative to dry cells.
Chemical modifications of LPS. (i) Preparation of LPS-OH. LPS (38 mg) was dissolved in an aqueous solution of triethylamine (0.02%, 5 ml), and sodium hydroxide (40 mg) was added. The alkaline solution was kept at 100°C for 1 h, cooled to room temperature, neutralized with hydrochloric acid (4 M), and desalted by being passed through a Sephadex G-25 column equilibrated with water. The void volume fractions were pooled and freeze-dried to give de-O-acylated LPS (LPS-OH, 32.2 mg).
(ii) Preparation of LPS-OH-HF. LPS-OH (32 mg) was dissolved in 48% aqueous hydrofluoric acid (2 ml) and stirred in a closed Teflon vial at 4°C for 48 h. The mixture was diluted with distilled water (8 ml), dialyzed extensively against distilled water, and lyophilized. The yield of de-Oacylated, dephosphorylated material (LPS-OH-HF) was 16.8 mg.
(iii) Preparation of lipid A-NaOAc, lipid A-HOAc, and lipid A-HCI. To a solution of LPS (35 mg), in aqueous triethylamine (0.02%, 7 ml), sodium acetate (NaOAc) buffer (1 M, pH 4.0, 1 ml) was added, and the mixture was kept at 100°C for 2 h. After being cooled, the solution was acidified with 1 M HCI to pH 2.0, kept for 2 h at 4°C, centrifuged, washed twice with a 0.3% solution of acetic acid (HOAc, 2 ml), and lyophilized (yield of lipid A-NaOAc, 12.7 mg [29%]). The supernatant was purified by Sephadex G-25 chromatography and lyophilized. It represents the oligosaccharide fraction used for 31P nuclear magnetic resonance (NMR) and methylation analyses (see below).
Lipid A-HOAc was prepared by dissolving LPS (20 mg) in aqueous triethylamine (0.02%, 4 ml) and adding HOAc to a final concentration of 1.5% (vol/vol). The mixture was heated (2 h, 100°C) and then cooled, and lipid A-HOAc was quantitatively precipitated by adding 1 M HCl to a final pH of 1.5. The insoluble lipid A-HOAc was centrifuged, washed three times with cold water (3 ml), and lyophilized (yield of lipid A-HOAc, 5.5 mg [28%]).
For the preparation of lipid A-HCl, LPS (100 mg) was dissolved in aqueous triethylamine (0.02%, 10 ml), 1 ml of 1 M HCl was added, and the mixture was kept at 100°C for 30 min. The precipitate was centrifuged and washed with water (2 ml), and the sediment was freeze-dried to yield lipid A-HCl (20 mg).
(iv) Preparation of lipid A-HClI.d. A portion of lipid A-HCl (20 mg) was dissolved in a 0.02% aqueous triethylamine solution (4 ml), crystalline sodium borohydride (25 mg) was added, and the mixture was heated at 56°C for 10 h. Excess of the reagent was destroyed by the addition of HOAc and the reduced material (lipid A-HClred) was dialyzed against HOAc (0.3%) and lyophilized (yield of lipid A-HClred, 16 mg [80%]).
(v) Preparation of lipid A-HF. LPS (10 mg) was suspended in 48% aqueous hydrogen fluoride (10 ml) and kept at 4°C for 48 h with stirring. After dialysis, the lyophilized retentate was treated with HOAc (1%, 100°C, 2 h) and centrifuged, and the sediment was washed with HOAc and freeze-dried. The yield of lipid A-HF was 5 mg.
(vi) Preparation of lipid A backbone. A sample of lipid A-HClred (33 mg) was suspended in anhydrous hydrazine (2 ml) and kept in a sealed ampoule at 100°C for 48 h. Hydrazine was removed by evaporation in a vacuum desiccator over concentrated H2SO4, and the residue was subjected to N acetylation according to the method of Hase and Rietschel (16) (1 ml) containing trimethyloxonium tetrafluoroborate (100 mg; Aldrich Chemical Co.) and 2,6-di-tert-butyl-4-methylpyridine (40 mg; Aldrich) , and the suspension was stirred in a capped vial at room temperature for 24 h. After the addition of sodium hydroxide (4 M, 1 ml), the reaction mixture was extracted with chloroform (three times, 1 ml each), and the organic phases were pooled, washed with water (two times, 1 ml each), and evaporated to dryness.
Other degradation and derivatization reactions. Esterbound fatty acids were liberated by alkaline methanolysis (0.25 M NaOMe, 4°C, 16 h) (43) . Acidic methanolysis was performed with HCl in methanol (1 M, 85°C, 1 h) in sealed ampoules. The R-and S-configurations of the 3-hydroxylated fatty acids were determined by gas-liquid chromatography (GLC) as their (R)-phenylethylamide derivatives according to the method of Rietschel (31) . For the methylation analysis of LPS-OH-HF and lipid A backbone preparations, samples (5 mg) were permethylated by using the procedure previously described by Ciucanu and Kerek (12) . After acetolysis, reduction with NaB2H4, and peracetylation (38) , the materials were analyzed by combined GLC-mass spectrometry (MS).
Methods of chemical analysis. The phosphate content was determined according to the method of Lowry et al. (26) , and amino components (GlcN, 2-aminoethanol, and their phosphate derivatives) were analyzed after strong-acid hydrolysis (4 M HCl, 14 h, 100°C) with an amino acid analyzer (Alpha Plus 4151; LKB). The total amount of GlcN was determined before and after sodium borohydride reduction by applying the Morgan-Elson reaction as modified and described by Strominger et al. (40) , either without or after acid hydrolysis (4 M HCI).
Chromatographic and electrophoretic techniques. Gel-permeation chromatography was performed on a Sephadex G-25 column (49 by 2 cm) or a TSK-HW40(S) (Merck) column (1 by 98 cm) by using water and HOAc (0.3%) as eluents, respectively; the eluates were monitored at 206 nm (Unicord S; LKB). The HPLC conditions for the analysis of the lipid A backbone were as previously described (18) . High-voltage paper electrophoresis of amino components was performed as described previously (18) . GLC was carried out with a model 3700 Varian gas chromatograph (Walnut Creek, Calif.) by using a fused silica capillary column (SE-54 chemically bonded, 25 m by 0.2 mm). The temperature program for the analysis of fatty acid methyl esters, (R)-phenylethylamides, and partially methylated hexosaminitol acetates was 150°C for 3 min followed by increases of 5°C/min to 250°C. Permethylated GlcNAc derivatives carrying amide-bound 3-methoxytetradecanoic acid and dimethylphosphate were chromatographed at a temperature gradient starting from 200°C for 3 min, with the temperature raised at a rate of 10°C/min to 320°C.
Combined GLC-MS, LDMS, and NMR spectroscopy. Combined GLC-MS was performed as described previously (18, 43) . Laser desorption mass spectrometry (LDMS) was performed with a laser microprobe mass analyzer (LAMMA 500; Leybold AG, Koln, Germany). Instrumental setting and sample preparation for the generation of positive-ion mass spectra of dephosphorylated lipid A were carried out as described previously (18, 25 The following experiments were performed to obtain detailed knowledge of how the various components in N. meningitidis lipid A are interlinked and to prove or disprove the above conclusions.
Location of phosphoryl groups and their substitution. The structural analysis of the lipid A backbone was carried out as previously described (23) . A strong-acid hydrolysate (4 M HCl) of lipid A-HClred contained GlcN (plus GlcN phosphate) and 2-amino-2-deoxy-D-glucitol in a ratio of 1.4:1.0, as determined with an amino acid analyzer. Lipid A-HClred was subjected to hydrazinolysis, and high-voltage paper electrophoresis of the deacylated and dephosphorylated material revealed a major component, with an MG1CN (migration pattern relative to GlcN) of 1.15, which readily reacted with ninhydrin. After elution from the paper, N acetylation, and purification [TSK-HW40(S)], a disaccharide, which was permethylated and analyzed by GLC-MS, was obtained. One peak which migrated and fragmented like an authentic permethylated P-D-GlcNpAc-(1'---6)-GlcNAc-ol disaccharide was obtained (21) . This disaccharide was further subjected to methylation analysis (acetolysis, reduction [NaBH4], and peracetylation). By GLC-MS, two major components were identified: Localization of phosphate substituents in the oligosaccharide and lipid A-NaOAc fractions of LPS. The broad-band 'H-decoupled 31P-NMR spectrum of LPS revealed that six major monophosphate and diphosphate resonances form three distinguishable groups of signals, which are presented in Table 2 . To identify the structural regions to which these resonances belong, the 31P-NMR spectra of lipid A-NaOAc and the oligosaccharide fraction were also recorded. The assignment of resonances was readily achieved by comparison with previously published data (10, 24, 36, 39) . The analysis of the spectra showed that two different pyrophos- (19, 29) are located in the oligosaccharide region (-0.09 and +0.23 ppm). In addition, glycosidic monophosphate (1-a-P, -1.79 ppm) and nonglycosidic (4'-P, -3.87 ppm) monophosphate groups were identified.
In the LPS, two signals deriving from the nonglycosidic substituted (+12.42 ppm, 4'-Etn-PP) and nonsubstituted phosphate (-3.87 ppm, 4'-P) indicated heterogeneity with respect to the replacement of the 4'-phosphate by Etn-P. The integral over both signals showed that the degree of substitution of Etn-P for 4'-P is about 85%. On the other hand, two different signals were assigned to the glycosidic phosphate, i.e., one pyrophosphate diester (O-pyrophosphorylethanolamine [1-a-Etn-PP], +11.24 ppm) and one glycosidic monophosphate (1-a-P, -1.79 ppm). Again, the intensities of both signals indicated a further heterogeneity in the substitution of Etn-P for the glycosidic phosphate (80%) in LPS.
This result was further confirmed by 31P-NMR data obtained with lipid A-NaOAc. The heterogeneity with respect to the degree of replacement of 4'-P (by Etn-P) was almost identical (80%) compared with that in LPS, indicating that the nonglycosidic Etn-PP-4' linkage was not cleaved during NaOAc hydrolysis. However, the intensity of the signal assigned to 1-a-Etn-PP (+11.24 ppm) was reduced in the 31P-NMR spectrum of lipid A-NaOAc compared with that of LPS. Moreover, the integrals of resonances assigned to the glycosidic monophosphate (1-P, -1.80 ppm) and the glycosidic pyrophosphate diester (1-Etn-PP, + 11.24 ppm) showed similar intensities (45 and 55%, respectively), indicating that in lipid A-NaOAc, part of the pyrophosphate linkage had been cleaved during acetate hydrolysis. Furthermore, this experiment showed that NaOAc hydrolysis did not cleave the pyrophosphate linkage in Etn-PP-4', whereas part of it was hydrolyzed in the glycosidic 1-a-Etn-PP. These results are in good agreement with the chemical analysis and the GlcN and phosphate values discussed above.
To gain independent proof of the position of the nongly- (Fig. 1B) exhibited a more diagnostic fragmentation pattern, providing information on the distribution of fatty acid residues in the lipid A backbone. In the spectrum, four (M + Na)+ ions were present at m/z's of 1,577 (hexaacyl), 1, 395 and C-4-C-5 bonds and of the C-1-C-2 and C-3-C-4 bonds, respectively (13, 41) . (15, 28) . The capsular polysaccharide of N. meningitidis group B in humans is not immunogenic and possesses both immunosuppressive and complement-inhibiting activities (22) . Also, the subcapsular component LPS contributes to the pathogenic potential of meningococci also because it induces, after being released from the bacterial cell, a variety of toxic effects culminating in irreversible septic shock. This paper describes results of structural analyses of the toxic principle of LPS of N. meningitidis serogroup B, i.e., the lipid A component. Our study shows that this lipid A consists of a ,-D-glucosaminyl-(1'-->6)-D-glucosamine disaccharide backbone carrying Etn-PP residues attached to hydroxyl groups at C-1 and C-4'. The same type of backbone has been postulated to be present in Neisseria gonorrhoeae lipid A (41). Bisphosphoryl lipid A lacking either Etn-P at the nonreducing phosphate (4'-P) or Etn at the reducing end (1-a-P) was present as a minor component (=15%), indicating heterogeneity in the substitution of polar head groups.
The hydroxyl groups at positions 4 and 6' were found to be free in oligosaccharide-deprived lipid A. In LPS, however, the 6' hydroxyl group is substituted by the oligosaccharide chain. It has previously been claimed that in Neissenia sicca lipid A, a I(1'--4)-linked GlcN disaccharide is present (3) . In light of this study, however, N. sicca lipid A should be reinvestigated by applying advanced chemical and physical methodologies.
The fatty acids present in N. meningitidis lipid A were identified, in accordance with previous studies of members of the family Neisseriaceae (2-4, 20, 41) , as 12:0, 12:0(3-OH) and 14:0(3-OH), the 3-hydroxylated acyl groups possessing the R configuration. On the basis of the number of fatty acids present, three lipid A species could be distinguished. Among these species, a hexaacyl component predominated, and glycosidic (1-a-P) phosphate groups are substituted nonstoichiometrically but, to a large extent (80 to 85%), by Etn-P. The reducing GlcN I residue is assumed to be present in the ot-anomeric form, and the 3-hydroxy fatty acids possess the R configuration. The hydroxyl group at C-6' represents the attachment site of the oligosaccharide portion. The numbers in circles show the number of atoms in acyl chains.
whereas minor species represented pentaacyl and tetraacyl lipid A. In the hexaacyl form, 12:0(3-OH) is bound to each of the two hydroxyl groups at positions 3 and 3', and 14:0(3-OH) is linked to the amino groups at positions 2 and 2', the hydroxyl groups of the amide-linked fatty acids being acylated by 12:0. The chemical structure of the predominant form of N. meningitidis lipid A, as characterized in this study, is shown in Fig. 2 .
As far as the nature and locations of acyl residues are concerned, this structure is identical to that described for N. gonorrhoeae (41) . Also, with N. gonorrhoeae, in addition to the hexaacyl component a pentaacyl species was characterized; however, it differs in structure from the pentaacyl lipid A studied here. Our LDMS results show that the major pentaacyl lipid A, compared with hexaacyl lipid A (Fig. 2) , lacks the 12:0 residue bound to 14:0(3-OH) at the terminal GlcN II group, whereas in pentaacyl lipid A of N. gonorrhoeae, the 12:0 residue bound to 14:0(3-OH) at the reducing GlcN I residue is absent (41) .
As Fig. 2 indicates, N. meningitidis lipid A belongs to the group of lipid A's possessing a symmetrical acylation pattern. This type of structure was first encountered in Chromobacterium violaceum (17, 33, 34) and, therefore, is referred to as a C. violaceum-type lipid A. Other members of this group are N. gonorrhoeae and Pseudomonas aeruginosa hexaacyl lipid A's (23, 41) . In the location of acyl groups, the lipid A differs from classical Escherichia colitype lipid A in that in E. coli, the fatty acids have asymmetrical distribution, the terminal GlcN II carrying four acyl groups and the reducing GlcN I residue carrying two acyl groups. As a rule, in C. violaceum-type lipid A preparations, the 3-hydroxy fatty acids possess an average chain length of less than 14, whereas the E. coli-type lipid A is associated with an average chain length of 3-hydroxy fatty acids of 14 or more. As a further distinction, in C. violaceum-type lipid A, the chain lengths of ester-and amide-bound 3-hydroxy fatty acids are often different (the amide-linked groups always being the ones with the longer chain), whereas in the E. coli-type lipid A, ester-and amide-linked 3-hydroxy fatty acids often possess the same number of carbon atoms.
As shown in this study, both phosphate groups at positions 1 and 4' of the P(1'--6)-linked D-GIcN disaccharide of N. meningitidis lipid A are nonstoichiometrically substituted by Etn-P to a similar degree. With Salmonella minnesota (10), Yersinia pestis (14) , and Rhodobacter capsulatus (27) , it has been previously shown that the glycosidic position is substituted, in part, by Etn-PP. The hydroxyl group at position 4', on the other hand, carries Etn in the case of lipid A of Rhodopseudomonas gelatinosa (27) and Rhodobacter capsulatus (27) . With the exception of Campylobacterjejuni (30) , in which a minor fraction was also found to contain Etn-PP at both positions 1 and 4', N. meningitidis lipid A appears to be unique with respect to the quantitative substitution of Etn-PP as a polar head group at both ends. It remains to be studied whether N. gonorrhoeae lipid A also contains pyrophosphoryl groups. In the only study performed so far (41), the structure of monophosphoryl lipid A was elucidated; the monophosphoryl lipid A was prepared by treatment of LPS with acid, thus liberating substituents of the glycosidic hydroxyl group and probably splitting pyrophosphate linkages. To circumvent these drastic degradation processes, a procedure which involves treatment of LPS with mild acid in the presence of detergents was recently proposed (11) . In this respect, the methodological approach to lipid A structural analysis which was used here and which was based on the application of 31P-NMR spectroscopy has evident advantages. The comparative analysis of 31P-NMR spectra recorded in sequence with LPS, degraded oligosaccharide, and free lipid A avoids difficulties in the identification and location of different phosphate-containing substituents and allows the identification and location of free and substituted phosphate groups in all structural regions of the LPS molecule.
In summary, N. meningitidis lipid A shares many structural features with other toxic lipid A's, such as the 1,4'-bisphosphorylated P(1'->6)-linked D-glucosamine backbone and the presence of ester-and amide-linked 3-hydroxy fatty acids (33, 35) . It contains amide-bound (R)-3-acyloxyacyl groups but lacks such groups in ester,linkage. N. meningitidis lipid A, thus, differs from E. coli-type lipid A in the locations (and chain lengths) of acyl groups. As a peculiar feature, both phosphate groups of the meningococcal lipid A backbone are substituted by O-phosphorylethanolamine.
Thus, the N. meningitidis lipid A exhibits a highly symmet-rical structure with regard to the distribution of both fatty acids and polar phosphate substituents.
